原创《布地奈德气雾剂对小儿肺炎的临床治疗作用》：本论文为您写小儿肺炎毕业论文范文和职称论文提供相关论文参考文献，可免费下载。
[摘 要] 目的 探究布地奈德气雾剂对小儿肺炎的临床疗效.方法 方便选取2015年7月—2016年8月该院进行治疗的小儿肺炎患者88例,将其随机分为对照组、治疗组各44例,对照组患者采用阿奇霉素静脉滴注治疗,治疗组患者采用布地奈德气雾剂吸入治疗,比较两组治疗前后的TNF-α、IgG、IgE各项免疫指标、不良反应发生率以及临床疗效. 结果 与对照组相比,观察组患者的各项免疫指标改善程度相对较大；经过治疗后治疗组的總有效率（88.64%）显著高于对照组,不良反应率为29.55%低于对照组,差异有统计学意义（P<0.05）. 结论 使用布地奈德气雾剂治疗小儿肺炎疗效确切,不良反应发生率较小,是治愈小儿肺炎患儿的理想方法,值得推广使用.
[关键词] 布地奈德气雾剂；小儿肺炎；临床疗效
[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742（2018）02（b）-0146-03
[Abstract] Objective This paper tries to investigate the clinical effect of budesonide aerosol on pediatric pneumonia. Methods 88 patients with pediatric pneumonia admitted to ENT Hospital of Daqing Oilfield from July 2015 to August 2016 were conveniently selected as the research objects which were randomly divided into control group and treatment group with 44 cases in each group. The control group received the azithromycin intrenous drip treatment, the treatment group were given the budesonide aerosol inhalation treatment, the TNF-, IgG, IgE immune indexes, incidence of adverse reactions and clinical efficacy were compared between the two groups before and after the treatment. Results Compared with the control group, the degree of the improvement of various immune indicators in the observation group was relatively large； after the treatment, the total effective rate of the treatment group （88.64%） was significantly higher than that of the control group, and the adverse reaction rate was 29.55%, which was lower than that of the control group. So the difference was statistically significant （P<0.05）. Conclusion Using budesonide aerosol for the treatment of infantile pneumonia is effective, and its incidence of adverse reactions is small. So it is an ideal method to cure children with pneumonia, and it is worth popularizing.
[Key words] Budesonide aerosol； Children pneumonia； Clinical curative effect
小儿肺炎属于儿科中常见的呼吸道疾病之一,尤多见于婴幼儿,也是造成婴儿时期死亡的主要原因[1].该病又称为小叶肺炎,多发于春冬寒冷季节以及天气骤变之时[2].小儿肺炎多由细菌或病毒引起,严重威胁患儿生命安全.不仅如此,由于婴幼儿免疫系统尚未发育完全,好转时若稍不注意防护将会因免疫力不持久而再次受到病毒感染[3-4].如何迅速有效地治疗小儿肺炎是医疗界反复探究的课题.为此,该次研究方便选取该院2015年7月—2016年8月收治的44例小儿肺炎患儿进行布地奈德气雾剂治疗,现报道如下.
1 资料与方法
1.1 一般资料
该次研究对象均方便选取该院收治的88例小儿肺炎患儿,所选患儿的临床症状和各项检查指标均符合小儿肺炎的相关诊断标准.按照随机数表法将患儿均分为对照组和治疗组各44例,对照组患儿中男童24例,女童20例；年龄在1～5岁之间,平均年龄为（2.98±0.47）岁；病程为6～14 d,平均病程为（10.34±2.54）d.治疗组男童23例,女童21例；年龄在10个月～5岁之间,平均年龄为（2.46±0.69）岁；病程在7～15 d,平均病程为（10.77±2.71）d.两组患儿的临床资料对比中显示差异无统计学意义（P>0.05）,有可比性.
1.2 治疗方法
对对照组采取阿奇霉素（国药准字H20051466）静脉滴注治疗,使用500 mL的5%葡萄糖注射液（国药准字H11020792）将5 mL阿奇霉素注射液浓度稀释至1～2 mg/mL后进行静脉滴注,时间不少于60 min,1次/d,持续点滴治疗7 d.
小儿肺炎论文参考资料：
结论：布地奈德气雾剂对小儿肺炎的临床治疗作用为关于本文可作为小儿肺炎方面的大学硕士与本科毕业论文小儿肺炎论文开题报告范文和职称论文论文写作参考文献下载。
